Literature DB >> 20544851

In the hypoxic central nervous system, endothelial cell proliferation is followed by astrocyte activation, proliferation, and increased expression of the alpha 6 beta 4 integrin and dystroglycan.

Longxuan Li1, Jennifer V Welser, Paula Dore-Duffy, Gregory J del Zoppo, Joseph C Lamanna, Richard Milner.   

Abstract

Cerebral hypoxia induces a profound angiogenic response in the central nervous system (CNS). Using a mouse model of chronic cerebral hypoxia, we previously demonstrated that angiogenic vessels in the hypoxic CNS show marked upregulation of the extracellular matrix (ECM) protein fibronectin, along with increased expression of its major receptor, alpha 5 beta 1 integrin on brain endothelial cells (BEC). As cerebral hypoxia also leads to glial activation, the aim of the current study was to define the temporal relationship between BEC responses and glial cell activation in this model of cerebral hypoxia. This revealed that BEC fibronectin/alpha 5 beta 1 integrin expression and proliferation both reached maximal level after 4-day hypoxia. Interestingly, up to 4-day hypoxia, all dividing cells were BEC, but at later time-points proliferating astrocytes were also observed. GFAP staining revealed that hypoxia induced marked astrocyte activation that reached maximal level between 7- and 14-day hypoxia. As newly formed cerebral capillaries require ensheathment by astrocyte end-feet to acquire mature brain endothelium characteristics, we next examined how expression of astrocyte end-feet adhesion molecules is regulated by hypoxia. This showed that the astrocyte adhesion receptors alpha 6 beta 4 integrin and dystroglycan were both markedly upregulated, with a time-course that closely resembled astrocyte activation. Taken together, this evidence shows that cerebral hypoxia promotes first an endothelial response, in which fibronectin promotes BEC proliferation. This is then followed by an astrocyte response, involving astrocyte activation, proliferation, and reorganization of astrocyte end-feet, which correlates with increased expression of astrocyte end-feet adhesion molecules. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544851      PMCID: PMC2914614          DOI: 10.1002/glia.20995

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  39 in total

Review 1.  Physiologic angiodynamics in the brain.

Authors:  Paula Dore-Duffy; Joseph C LaManna
Journal:  Antioxid Redox Signal       Date:  2007-09       Impact factor: 8.401

2.  Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis.

Authors:  Stefanie Robel; Tetsuji Mori; Saida Zoubaa; Jürgen Schlegel; Svetlana Sirko; Andreas Faissner; Sandra Goebbels; Leda Dimou; Magdalena Götz
Journal:  Glia       Date:  2009-11-15       Impact factor: 7.452

3.  Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion.

Authors:  B A Miller; R S Perez; A R Shah; E R Gonzales; T S Park; J M Gidday
Journal:  Neuroreport       Date:  2001-06-13       Impact factor: 1.837

4.  Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia.

Authors:  J C Chávez; F Agani; P Pichiule; J C LaManna
Journal:  J Appl Physiol (1985)       Date:  2000-11

5.  Stress response to hypoxia in gerbil brain: HO-1 and Mn SOD expression and glial activation.

Authors:  P Garnier; C Demougeot; N Bertrand; A Prigent-Tessier; C Marie; A Beley
Journal:  Brain Res       Date:  2001-03-02       Impact factor: 3.252

6.  Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse.

Authors:  Zheng Gang Zhang; Li Zhang; Quan Jiang; Michael Chopp
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

7.  Increased expression of fibronectin and the alpha 5 beta 1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia.

Authors:  Richard Milner; Stephanie Hung; Bernadette Erokwu; Paula Dore-Duffy; Joseph C LaManna; Gregory J del Zoppo
Journal:  Mol Cell Neurosci       Date:  2008-02-13       Impact factor: 4.314

8.  Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.

Authors:  Steven A Moore; Fumiaki Saito; Jianguo Chen; Daniel E Michele; Michael D Henry; Albee Messing; Ronald D Cohn; Susan E Ross-Barta; Steve Westra; Roger A Williamson; Toshinori Hoshi; Kevin P Campbell
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

9.  The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent.

Authors:  Richard Milner; Stephanie Hung; Xiaoyun Wang; Maria Spatz; Gregory J del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2007-11-21       Impact factor: 6.200

10.  Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia.

Authors:  Il Kwon; Eun Hee Kim; Gregory J del Zoppo; Ji Hoe Heo
Journal:  J Neurosci Res       Date:  2009-02-15       Impact factor: 4.164

View more
  33 in total

Review 1.  Neurovascular unit: a focus on pericytes.

Authors:  Inês Sá-Pereira; Dora Brites; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2012-02-28       Impact factor: 5.590

2.  An angiogenic role for the α5β1 integrin in promoting endothelial cell proliferation during cerebral hypoxia.

Authors:  Longxuan Li; Jennifer Welser-Alves; Arjan van der Flier; Amin Boroujerdi; Richard O Hynes; Richard Milner
Journal:  Exp Neurol       Date:  2012-06-18       Impact factor: 5.330

Review 3.  Oxygen levels and the regulation of cell adhesion in the nervous system: a control point for morphogenesis in development, disease and evolution?

Authors:  Kathryn L Crossin
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

4.  Brain regional angiogenic potential at the neurovascular unit during normal aging.

Authors:  Nivetha Murugesan; Tyler G Demarest; Joseph A Madri; Joel S Pachter
Journal:  Neurobiol Aging       Date:  2011-10-21       Impact factor: 4.673

Review 5.  Immunologic privilege in the central nervous system and the blood-brain barrier.

Authors:  Leslie L Muldoon; Jorge I Alvarez; David J Begley; Ruben J Boado; Gregory J Del Zoppo; Nancy D Doolittle; Britta Engelhardt; John M Hallenbeck; Russell R Lonser; John R Ohlfest; Alexandre Prat; Maurizio Scarpa; Richard J Smeyne; Lester R Drewes; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

6.  Chronic cerebral hypoxia promotes arteriogenic remodeling events that can be identified by reduced endoglin (CD105) expression and a switch in β1 integrins.

Authors:  Amin Boroujerdi; Jennifer V Welser-Alves; Ulrich Tigges; Richard Milner
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-27       Impact factor: 6.200

7.  Physiological cerebrovascular remodeling in response to chronic mild hypoxia: A role for activated protein C.

Authors:  Laurent Burnier; Amin Boroujerdi; Jose A Fernández; Jennifer V Welser-Alves; John H Griffin; Richard Milner
Journal:  Exp Neurol       Date:  2016-07-10       Impact factor: 5.330

8.  A critical role for microglia in maintaining vascular integrity in the hypoxic spinal cord.

Authors:  Sebok K Halder; Richard Milner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-26       Impact factor: 11.205

9.  Transient acidification and subsequent proinflammatory cytokine stimulation of astrocytes induce distinct activation phenotypes.

Authors:  Nicole A Renner; Hope A Sansing; Fiona M Inglis; Smriti Mehra; Deepak Kaushal; Andrew A Lackner; Andrew G Maclean
Journal:  J Cell Physiol       Date:  2013-06       Impact factor: 6.384

10.  Endothelial β4 integrin is predominantly expressed in arterioles, where it promotes vascular remodeling in the hypoxic brain.

Authors:  Jennifer V Welser-Alves; Amin Boroujerdi; Ulrich Tigges; Lawrence Wrabetz; M Laura Feltri; Richard Milner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-07       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.